Scientific publishing is a cornerstone of disseminating knowledge. One caveat of scientific publishing is that at any one time it is biased toward certain topics relative to others, a reflection of the dynamic nature of scientific discovery over time and the emergence of new technologies. As a result, some areas of cancer biology remain understudied and poorly understood. This reality is compounded by additional factors at play. For example, the ability to bridge gaps in knowledge may prove difficult if investigators from disparate fields are unaware of each other's work; such investigators may be located in entirely different institutions, if not countries. Alternatively, some areas of cancer research have remained understudied because there is a need for technologies or datasets that have yet to be created. Collectively, these “missed” opportunities within scientific publishing that are centered within the realm of convergence science represent an opportunity for Cancer Research.

To...

You do not currently have access to this content.